Cardiology Department, Ibn Rochd University Hospital, Casablanca, Morocco.
*Corresponding Author : Hamza Karmouchi
Cardiology Department, Ibn Rochd University
Hospital, Casablanca, Morocco.
Tel: 21-2674200355;
Email:[email protected]
Received : Sep 23, 2024
Accepted : Oct 14, 2024
Published : Oct 21, 2024
Archived : www.jcimcr.org
Copyright : © Karmouchi H (2024).
Keywords: Barlow’s disease; Ebstein’s anomaly; Echocardiography.
A 37-year-old male was referred for cardiology evaluation following the incidental discovery of a heart murmur during a routine examination by his primary care physician. The patient was asymptomatic with no prior history of cardiovascular disease. Clinical examination revealed a holosystolic murmur at the apex, suggestive of mitral regurgitation. Transthoracic Echocardiography (TTE) showed a myxomatous mitral valve with prolapse of the A2-A3 segments, consistent with Barlow’s disease, leading to moderate-to-severe mitral regurgitation (Figure 1). Left ventricular function was preserved with an ejection fraction of 65%, and no left ventricular dilation was observed.
Further evaluation revealed an apical displacement of the septal leaflet of the tricuspid valve, characteristic of Ebstein’s anomaly (Figure 2). The tricuspid regurgitation was mild, with no right ventricular dilation or pulmonary hypertension. This rare association of Barlow’s disease and Ebstein’s anomaly underscores the complexity of congenital valvular abnormalities and their clinical implications. The coexistence of these two distinct pathologies poses unique diagnostic and therapeutic challenges, as their progression and management may differ significantly. This necessitates careful longitudinal monitoring and a multidisciplinary approach to treatment planning. Early recognition is crucial to prevent complications such as heart failure, arrhythmias, and the potential need for surgical intervention. Few cases of this association have been reported in the literature, emphasizing the uniqueness of this case [1]. The patient is currently under conservative management with regular follow-up to monitor the progression of both valvular conditions.
Ethical approval: Written informed consent was obtained from the patient described in this article.
Funding: No funding has been received to carry out the work described in this manuscript.
Conflict of interest: None.